Monograph of Metoclopramide
Introduction Metoclopramide is a synthetic, first‑generation dopamine D2 receptor antagonist that also exhibits serotonergic activity at 5‑HT3 receptors. It was first synthesized in the early 1970s and subsequently approved for clinical use in the United Kingdom and the United States during the late 1970s. Over the decades, it has become a cornerstone in the management…